Cargando…

Empagliflozin prevents neointima formation by impairing smooth muscle cell proliferation and accelerating endothelial regeneration

BACKGROUND: Empagliflozin, an inhibitor of the sodium glucose co-transporter 2 (SGLT2) and developed as an anti-diabetic agent exerts additional beneficial effects on heart failure outcomes. However, the effect of empagliflozin on vascular cell function and vascular remodeling processes remains larg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dutzmann, Jochen, Bode, Lena Marie, Kalies, Katrin, Korte, Laura, Knöpp, Kai, Kloss, Frederik Julius, Sirisko, Mirja, Pilowski, Claudia, Koch, Susanne, Schenk, Heiko, Daniel, Jan-Marcus, Bauersachs, Johann, Sedding, Daniel G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396257/ https://www.ncbi.nlm.nih.gov/pubmed/36017090 http://dx.doi.org/10.3389/fcvm.2022.956041

Ejemplares similares

The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury
por: Dutzmann, Jochen, et al.
Publicado: (2017)

Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation
por: Daniel, Jan-Marcus, et al.
Publicado: (2012)

Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury
por: Daniel, Jan-Marcus, et al.
Publicado: (2014)

The differential statin effect on cytokine production of monocytes or macrophages is mediated by differential geranylgeranylation-dependent Rac1 activation
por: Fu, Hang, et al.
Publicado: (2019)

Emerging translational approaches to target STAT3 signalling and its impact on vascular disease
por: Dutzmann, Jochen, et al.
Publicado: (2015)

Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease
por: Sedding, Daniel G., et al.
Publicado: (2018)

Normal endothelial but impaired arterial development in MAP-Kinase activated protein kinase 2 (MK2) deficient mice
por: Napp, L. Christian, et al.
Publicado: (2016)

Erratum to: ‘Normal endothelial but impaired arterial development in MAP-Kinase activated protein kinase 2 (MK2) deficient mice’
por: Napp, L. Christian, et al.
Publicado: (2016)

Effect of intermittent fasting after ST-elevation myocardial infarction on left ventricular function: study protocol of a pilot randomised controlled trial (INTERFAST-MI)
por: Dutzmann, Jochen, et al.
Publicado: (2022)

Inflammatory Drivers of Cardiovascular Disease: Molecular Characterization of Senescent Coronary Vascular Smooth Muscle Cells
por: Stojanović, Stevan D., et al.
Publicado: (2020)

Bilirubin Inhibits Neointima Formation and Vascular Smooth Muscle Cell Proliferation and Migration
por: Peyton, Kelly J., et al.
Publicado: (2012)

Xanthohumol Blocks Proliferation and Migration of Vascular Smooth Muscle Cells in Vitro and Reduces Neointima Formation in Vivo
por: Liu, Rongxia, et al.
Publicado: (2017)

Targeting of Extracellular RNA Reduces Edema Formation and Infarct Size and Improves Survival After Myocardial Infarction in Mice
por: Stieger, Philipp, et al.
Publicado: (2017)

Gastrodin inhibits cell proliferation in vascular smooth muscle cells and attenuates neointima formation in vivo
por: ZHU, LIHUA, et al.
Publicado: (2012)

Defective autophagy in vascular smooth muscle cells accelerates senescence and promotes neointima formation and atherogenesis
por: Grootaert, Mandy OJ, et al.
Publicado: (2015)

Genistein suppresses leptin‐induced proliferation and migration of vascular smooth muscle cells and neointima formation
por: Tsai, Yung‐Chieh, et al.
Publicado: (2016)

Combined treatment with DPP-4 inhibitor linagliptin and SGLT2 inhibitor empagliflozin attenuates neointima formation after vascular injury in diabetic mice
por: Takahashi, Hiroyuki, et al.
Publicado: (2019)

The G534E polymorphism of the gene encoding the factor VII–activating protease is associated with cardiovascular risk due to increased neointima formation
por: Sedding, Daniel, et al.
Publicado: (2006)

Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis
por: Stojanović, Stevan D, et al.
Publicado: (2020)

Previously differentiated medial vascular smooth muscle cells contribute to neointima formation following vascular injury
por: Herring, Brian Paul, et al.
Publicado: (2014)

Interferon Regulatory Factor 7 Protects Against Vascular Smooth Muscle Cell Proliferation and Neointima Formation
por: Huang, Ling, et al.
Publicado: (2014)

Role of FOXM1 in vascular smooth muscle cell survival and neointima formation following vascular injury
por: Franco, Sarah, et al.
Publicado: (2020)

Mediator Med23 deficiency in smooth muscle cells prevents neointima formation after arterial injury
por: Sun, Xiaoli, et al.
Publicado: (2021)

USP10 exacerbates neointima formation by stabilizing Skp2 protein in vascular smooth muscle cells
por: Xia, Xiaohong, et al.
Publicado: (2021)

Smooth Muscle–Selective Inhibition of Nuclear Factor‐κB Attenuates Smooth Muscle Phenotypic Switching and Neointima Formation Following Vascular Injury
por: Yoshida, Tadashi, et al.
Publicado: (2013)

MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells
por: Filippov, Sergey, et al.
Publicado: (2005)

PDZK1 Prevents Neointima Formation via Suppression of Breakpoint Cluster Region Kinase in Vascular Smooth Muscle
por: Lee, Wan Ru, et al.
Publicado: (2015)

Migration of smooth muscle cells from the arterial anastomosis of arteriovenous fistulas requires Notch activation to form neointima
por: Liang, Ming, et al.
Publicado: (2015)

Telomerase Inhibition by Everolimus Suppresses Smooth Muscle Cell Proliferation and Neointima Formation Through Epigenetic Gene Silencing
por: Aono, Jun, et al.
Publicado: (2016)

Oxidative stress induces early-onset apoptosis of vascular smooth muscle cells and neointima formation in response to injury
por: Gomez, Camilo, et al.
Publicado: (2015)

miR-22 Is a Novel Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation and Neointima Formation
por: Yang, Feng, et al.
Publicado: (2018)

Tollip Negatively Regulates Vascular Smooth Muscle Cell–Mediated Neointima Formation by Suppressing Akt‐Dependent Signaling
por: Zhi, Hong, et al.
Publicado: (2018)

Homer binds to Orai1 and TRPC channels in the neointima and regulates vascular smooth muscle cell migration and proliferation
por: Jia, Shuping, et al.
Publicado: (2017)

TSPO ligands prevent the proliferation of vascular smooth muscle cells and attenuate neointima formation through AMPK activation
por: Wu, Lian-pan, et al.
Publicado: (2019)

Activation of TFEB ameliorates dedifferentiation of arterial smooth muscle cells and neointima formation in mice with high-fat diet
por: Wang, Yun-Ting, et al.
Publicado: (2019)

Smooth muscle cells-specific loss of OCT4 accelerates neointima formation after acute vascular injury
por: Shin, Junchul, et al.
Publicado: (2023)

Poldip2 Knockdown Inhibits Vascular Smooth Muscle Proliferation and Neointima Formation by Regulating the Expression of PCNA and p21
por: Datla, Srinivasa Raju, et al.
Publicado: (2018)

Adipose differentiation-related protein knockdown inhibits vascular smooth muscle cell proliferation and migration and attenuates neointima formation
por: Zhao, Haomin, et al.
Publicado: (2017)

Author Correction: Mediator Med23 deficiency in smooth muscle cells prevents neointima formation after arterial injury
por: Sun, Xiaoli, et al.
Publicado: (2023)

Safety and efficacy of renal sympathetic denervation: a 9-year long-term follow-up of 24-hour ambulatory blood pressure measurements
por: Vogt, Alexander, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_huv84301dth9sca91f5b30kl4u